Showing results (161-170 of 398) with videos related to
Sort By:
Pageof 40
The American Journal of Cardiology|September 29, 2000
Impact of enoxaparin low molecular weight heparin in patients with Q-wave myocardial infarctionM Cohen, E M Antman, E Gurfinkel, et al.The New England Journal of Medicine|January 28, 1982
Adjusted subcutaneous heparin versus warfarin sodium in the long-term treatment of venous thrombosisR Hull, T Delmore, C Carter, et al.Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|September 27, 2015
Rivaroxaban for Thromboprophylaxis After Fracture-Related Orthopedic Surgery in Routine Clinical PracticeMichael R Lassen, Sylvia Haas, Reinhold Kreutz, et al.Thrombosis Research|February 7, 2018
Effectiveness and safety of outpatient rivaroxaban versus warfarin for treatment of venous thromboembolism in patients with a known primary hypercoagulable stateCraig I Coleman, Alexander G G Turpie, Thomas J Bunz, et al.The American Journal of Medicine|December 25, 2018
Impact of Prolonged Anticoagulation with Rivaroxaban on Provoked Venous Thromboembolism Recurrence: IMPROVE-VTECraig I Coleman, Alexander G G Turpie, Thomas J Bunz, et al.Thrombosis Journal|August 6, 2014
XALIA: rationale and design of a non-interventional study of rivaroxaban compared with standard therapy for initial and long-term anticoagulation in deep vein thrombosisWalter Ageno, Lorenzo G Mantovani, Sylvia Haas, et al.Journal of Thrombosis and Haemostasis : JTH|January 7, 2005
Epidemiology of venous thromboembolism in Asian patients undergoing major orthopedic surgery without thromboprophylaxis. The SMART studyA Leizorovicz, A G G Turpie, A T Cohen, et al.Circulation|October 17, 2012
Efficacy and safety of the novel oral anticoagulants in atrial fibrillation: a systematic review and meta-analysis of the literatureFrancesco Dentali, Nicoletta Riva, Mark Crowther, et al.The Journal of Laboratory and Clinical Medicine|April 1, 1984
Clinical usefulness of testing for a heparin-dependent platelet-aggregating factor in patients with suspected heparin-associated thrombocytopeniaJ G Kelton, D Sheridan, H Brain, et al.The New England Journal of Medicine|August 19, 1993
A comparison of aspirin with placebo in patients treated with warfarin after heart-valve replacementA G Turpie, M Gent, A Laupacis, et al.Pageof 40